Simplified Chinese
Li Aifang, a member of the Party Leadership Group and Vice Chairperson of the Daxing District CPPCC, paid a visit to Minhai Biotechnology for inspection and guidance.
Release date:
2025-03-14
Author:
Source:
Abstract
Recently, Li Aifang, a member of the Party Leadership Group and Vice Chairperson of the Daxing District CPPCC in Beijing, paid a visit to Beijing Minhai Biotechnology Co., Ltd. to offer guidance. She toured the company’s corporate exhibition hall and the Internationalization Industrial Base for Novel Vaccines, and engaged in an in-depth exchange with Zheng Haifa, a member of the Daxing District CPPCC and General Manager of Minhai Biotechnology.
Li Aifang pointed out that vaccines are a vital industry, delivering social, innovative, and economic value. For decades, Minhai Biologics has remained steadfast in its commitment to the research, development, and production of human vaccines, earning recognition for the significant contributions it has made to China’s national infectious disease prevention and control efforts on behalf of Daxing District. Looking ahead, she expressed the hope that the company will continue to take root in Daxing, expand globally, and bring greater health benefits to the public through more high‑quality, highly effective, and innovative vaccines, while also setting an industry‑leading example in Daxing and helping to drive the robust growth of the region’s biopharmaceutical sector.

Keywords:
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09